Pro-inflammatory mediators produced by pathogenic Cutibacterium acnes subtypes

Pro-inflammatory mediators produced by pathogenic Cutibacterium acnes subtypes encompass a variety of bacterial products and host-derived signals that drive the inflammatory stage of acne vulgaris (Dréno et al., 2018, PMID: 29894579). Pathogenic strains, particularly those belonging to phylotype IA1, secrete enzymes such as lipases, proteases, and hyaluronate lyases that degrade follicular structures and release free fatty acids, further irritating the skin (Fitz-Gibbon et al., 2013, PMID: 23337890). These bacterial components act as pathogen-associated molecular patterns (PAMPs) that trigger the host's innate immune system via Toll-like receptors, specifically TLR2 and TLR4, on keratinocytes and sebocytes (Selway et al., 2013, PMID: 23883109). This interaction results in the secretion of potent host pro-inflammatory cytokines like IL-1β, IL-6, IL-8, and TNF-α, which recruit neutrophils and promote the formation of inflammatory papules and pustules (National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2020). Because this term describes a collective group of molecules rather than a single protein, it is not considered a discrete therapeutic target, though many acne treatments aim to mitigate the production or effects of these mediators. Therapeutic strategies typically focus on reducing the population of pathogenic C. acnes or modulating the host's inflammatory signaling cascades. For example, antibiotics like clindamycin reduce the bacterial source of these mediators, while retinoids like isotretinoin alter the microenvironment to be less conducive to pathogenic colonization.

Other names

C. acnes virulence factorsAcne-associated inflammatory mediatorsCutibacterium acnes exoproteinsPro-inflammatory cytokines in acne

Reduction of bacterial load, inhibition of sebum production, and suppression of host inflammatory cytokine production.